We have identified a cDNA from a human phytohemagglutinin-activated lymphoblast library encoding a protein that binds 125 
Interleukin 12 (IL-12) is a heterodimeric cytokine produced primarily by antigen-presenting cells that has important activities in the regulation of various aspects of the immune response. IL-12 stimulates proliferation of activated T and natural killer cells (1) (2) (3) (4) , enhances lymphokine-activated killer͞natural killer and cytotoxic T lymphocyte lytic activity (2, 5) , and induces IFN-␥ production by T and natural killer cells (6) (7) (8) . IL-12 plays a central role in promoting Th1-type immune responses and thus cell-mediated immunity (9) (10) (11) (12) (13) (14) . We have previously described the identification of a cDNA encoding an IL-12 receptor (R) protein, designated IL-12R␤. When expressed in COS-7 cells, IL-12R␤ mediates binding of 125 I-huIL-12 with a K d of about 2-5 nM, corresponding to the low affinity binding sites seen on PHA-activated lymphoblasts (17) . This IL-12R␤ chain is a member of the cytokine receptor superfamily, and is related most closely over its entire length to the ''␤ type'' (18) cytokine receptor glycoprotein (gp)130 and the receptors for leukemia inhibitory factor and granulocyte colony-stimulating factor. Although this IL-12R␤ protein has a short cytoplasmic tail, the box 1 and box 2 cytokine receptor motifs are present. In light of the important role of tyrosine phosphorylation in signal transduction pathways, it is interesting to note that there are no tyrosine residues present in the cytoplasmic tail of this IL-12R␤ protein. Nevertheless, antibody inhibition experiments demonstrated that anti-IL-12R␤ monoclonal antibodies were able to specifically inhibit IL-12-induced proliferation of PHA-activated lymphoblasts, production of interferon-␥ from resting peripheral blood mononuclear cells, and development of lymphokine-activated killer activity (19) , demonstrating that this IL-12R␤ protein is necessary for IL-12 signaling.
The inability to confer high affinity (K d of 5-20 pM) 125 I-huIL-12 binding to COS-7 cells transfected with the previously identified IL-12R␤ protein, as well as the lack of cytoplasmic tyrosine residues, suggested that at least one additional IL-12R subunit exists. We now report the identification, using expression cloning techniques, of an additional ␤ type IL-12 receptor protein. This receptor is designated IL-12R␤2, and the previously identified IL-12R␤ is therefore reclassified as IL-12R␤1. IL-12R␤2 by itself binds 125 I-huIL-12 with low affinity. When coexpressed with IL-12R␤1, it confers high-affinity 125 I-huIL-12 binding and IL-12 responsiveness.
described method (15, 21) incorporating low concentrations of 125 I-huIL-12 (about 30 pM) and a 3-hr wash at room temperature to allow for the selective measurement of high-affinity binding. By screening 440 pools and subsequent sib-selection, one positive cDNA was isolated and sequenced using an automated Applied Biosystems DNA sequencer. The corresponding mouse cDNA was isolated by crosshybridizationscreening of a cDNA library generated from concanavalin A-stimulated splenocyte mRNA. Standard recombinant DNA methods were used for additional library screening, probe labeling, and RNA blotting (22) . Preparation of Cell Lines. COS-7 cells were transfected by electroporation with expression constructs containing the indicated protein coding sequence in the pEF-BOS expression vector and harvested after 48-72 hr as described previously (17) . Ba͞F3-expressing huIL-12R␤1 were produced by electroporation with linearized pRC-Rous sarcoma virus-IL-12R DNA as previously described for production of cytotoxic T lymphocyte lytic cells expressing huIL-12R␤1 (17) . G-418-resistant clones were subcloned by limiting dilution, screened for huIL-12R␤1 expression by flow cytometry using the antihuIL-12R␤1 antibody 2-4E6 (19, 23) , and the resultant cell line designated Ba͞F3.huIL-12R␤1 cells. Linearized expression constructs encoding huIL-12R␤2 in the pEF-BOS expression vector and a puromycin resistance gene expression vector, pBSpac⌬p (24) , were introduced by electroporation into Ba͞F3 or Ba͞F3.huIL-12R␤1 cells, and stable transfectants were selected by growth in medium containing 10 ng͞ml IL-12 (a gift of Alvin Stern, Hoffmann-La Roche) or in IL-3-containing medium supplemented with 3 g͞ml puromycin (Sigma). The surviving cells were cloned by limiting dilution in IL-12-or puromycin-containing medium, as appropriate.
Characterization of huIL-12R␤2 Protein. Expression constructs encoding huIL-12R␤2 with the addition of a C-terminal FLAG peptide tag (25) were prepared in the pEF-BOS expression vector. COS-7 cells were transfected by electroporation with huIL-12R␤1 and͞or huIL-12R␤2-FLAG expression constructs as described above and metabolically labeled with [ 35 S]cysteine for 6 hr at 37ЊC. The cells were then solubilized in 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfate lysis buffer (CHAPS; 10 mM CHAPS͞50 mM Tris͞0.3 M NaCl͞500 mM iodoacetamide͞100 mM phenylmethylsulfonyl fluoride) at a density of 1 ϫ 10 6 cells per ml, and the cell lysates were immunoprecipitated by the addition of 5 g of the anti-FLAG M2 antibody bound to 50 l of GammaBind Plus Sepharose (Pharmacia). The immunoprecipitated proteins were analyzed by SDS͞PAGE 4-12% gradient gels, and the labeled proteins visualized by autoradiography.
IL-12 Binding and Proliferation Assays. 125 I-huIL-12 was prepared by the Iodogen method, and specific binding to cells was measured as described previously (15, 26) . Specific binding was analyzed using the LIGAND nonlinear regression computer program (27) and plotted by the method of Scatchard (28) . For measurement of IL-12-stimulated proliferation, Ba͞F3 cells expressing the indicated proteins were washed and cultured in RPMI medium 1640 supplemented with 10% fetal bovine serum, 100 units͞ml penicillin G, 100 g͞ml streptomycin, and 2 mM glutamine at 1 ϫ 10 4 cells per well in flat-bottom 96-well microculture plates at 37ЊC for 24 hr. Various concentrations of IL-12 were added, the cells were cultured for an additional 42 hr at 37ЊC, and the wells were then pulsed with 0.5 Ci (1 Ci ϭ 37 GBq) per well 3 H-thymidine (New England Nuclear) for 6 hr at 37ЊC. Incorporation of 3 H-thymidine into DNA was determined by harvesting the contents of each well onto glass fiber filters. All samples were assayed in triplicate.
RESULTS
Characterization of IL-12R␤2 cDNA. Using an expression cloning strategy that was specifically directed toward identifying high-affinity IL-12R, we have isolated a novel IL-12R cDNA. This cDNA, when coexpressed with the previously described IL-12R, reconstitutes a high-affinity IL-12R complex (see below). Due to its homology to other ␤-type cytokine receptor proteins (see below), we are proposing that this novel IL-12R be termed IL-12R␤2, and that the previously isolated IL-12R␤ (17) be renamed IL-12R␤1. The first IL-12R␤2 cDNA that was isolated contained a very long (640 bp) and GϩC-rich (73-78%) 5Ј noncoding region (data not shown). Analysis of four additional independent clones confirmed the presence of this unusual 5Ј end structure. Sequencing of the cDNAs showed the presence of one long open reading frame encoding an 862-amino acid (aa) protein (Fig. 1 ). This IL-12R␤2 is a type I transmembrane protein, with a predicted molecular weight of 97,140 Da (including the signal peptide) and 94,059 Da (predicted mature protein). An extracellular domain of 595 aa is separated by a 24-aa transmembrane region from a 216-aa cytoplasmic tail that contains three tyrosine residues. Fig. 1 also shows that the corresponding mouse IL-12R␤2 protein is very similar to the human receptor subunit, with an overall aa sequence identity of 68%.
IL-12R␤2 is a member of the cytokine receptor superfamily. Similar to IL-12R␤1, IL-12R␤2 is also most closely related to the members of the gp130-type subgroup (gp130, granulocyte colony-stimulating factor-R, leukemia inhibitory factor-R).
Comparison of the huIL-12R extracellular domains using the ALIGN program (29) yields scores of 20 (IL-12R␤2͞gp130), 8 (IL-12R␤1͞gp130), and 3 (IL-12R␤1͞IL-12R␤2). Scores greater than 3 are considered to demonstrate significant evolutionary relationships. A score of 3 indicates that the similarity would have occurred by chance with a probability of only 10 Ϫ3 , with increasing scores corresponding to decreasing probabilities. In contrast to IL-12R␤1, IL-12R␤2 contains an N-terminal Ig motif, and is thus more similar to gp130. The cytoplasmic region of IL-12R␤2 also contains the characteristic box 1 motif and a possible box 2 motif: thus, both cloned IL-12 receptor chains have the general makeup of a ␤-type subunit (18) .
RNA blot analysis of PHA-activated human lymphoblasts indicated the presence of two major transcripts of 4.5 and 6 kb ( Fig. 2) . Both mRNAs are up-regulated from undetectable or very low levels when peripheral blood mononuclear cells are treated with PHA. By analyzing uncloned cDNA from PHAactivated lymphoblasts using reverse transcription-PCR, we have not been able to detect any evidence for a soluble form of huIL-12R␤2, since variant transcripts in which the transmembrane encoding region is absent have not been found (data not shown). However, production of soluble forms of huIL-12R␤2 could result from proteolytic cleavage of the extracellular portion of this receptor subunit from the cell surface.
Characterization of the IL-12R Subunits in COS-7 Cells. COS-7 cells were transfected by electroporation with cDNA expression constructs for huIL-12R␤1 and huIL-12R␤2, alone and in combination, to investigate the functional properties of these proteins. As previously reported (17, 30) , huIL-12R␤1 mediates low affinity binding of 125 I-huIL-12, with a K d of about 10 nM and about 100,000 sites per cell (Fig. 3 Top) . Expression of huIL-12R␤2 in COS-7 cells yields similar results with a single class of 125 I-huIL-12 binding sites with a K d of about 5 nM (Fig. 3 Middle). When both proteins are coexpressed, two classes of binding sites can be detected (Fig. 3 Bottom). We have measured two classes of 125 I-huIL-12 binding sites in cotransfected COS-7 cells with K d s of 55 Ϯ 10 pM (1,860 Ϯ 380 sites per cell) and 7.5 Ϯ 0.6 nM (68,700 Ϯ 16,500 sites per cell) (n ϭ 8). The low number of high affinity sites detected on the cotransfected cells may be due to either competition for expression between huIL-12R␤1 and huIL-12R␤2 at the level of mRNA or protein, or may be due to competition between homo-and hetero-association of the ␤1 (23) .
Immunoprecipitation experiments were conducted to determine the biochemical properties of huIL-12R␤2. Cterminally FLAG-tagged huIL-12R␤2 protein was determined to have an apparent molecular weight of 130 kDa when expressed in COS-7 cells and analyzed by SDS͞PAGE under reducing conditions (Fig. 4) . Under nonreducing conditions, huIL-12R␤2 protein migrates as a protein with an apparent molecular weight Ͼ220 kDa, suggesting the IL-12-independent formation of disulfide-bonded dimers of huIL-12R␤2 in the transfected COS-7 cells. In addition, the existence of higher order multimers of huIL-12R␤2 is suggested by the appearance of high molecular weight material at the top of the electrophoresis gels. However, this material may be an artifact of Exposure time was 16 hr using an intensifying screen at Ϫ80ЊC. (Lower) As a loading control, the blot was rehybridized with a probe for a cell-cycle independent transcript, pHE7 (37) . Exposure time was 20 min using an intensifying screen at Ϫ80ЊC. solubilization. It is interesting that this dimer͞oligomer is still present when the samples are prepared in the presence of 700 mM 2-mercaptoethanol, demonstrating resistance of dimer͞ oligomer breakdown upon disulfide bond reduction. The protein migrating with an apparent molecular weight of 90 kDa is unrelated to the IL-12 receptor subunits as it appears in mock transfected COS-7 cells. Coimmunoprecipitation of the two IL-12 receptor subunits was not observed, as evidenced by the absence of the 100-kDa huIL-12R␤1 protein from the pattern of proteins immunoprecipitated by anti-FLAG antibody from cell lysates of COS-7 cells cotransfected with huIL-12R␤1 and huIL-12R␤2-FLAG (Fig. 4) . Additional experiments conducted in the presence of huIL-12 and chemical crosslinking agents also did not detect coimmunoprecipitation of heterodimeric ␤1͞␤2 protein complexes (data not shown).
Analysis of the Signaling Properties of the IL-12R Subunits. To investigate the role the various IL-12R subunits play in mediating IL-12 signal transduction, the Ba͞F3 IL-3-dependent mouse pro B cell line (31) was stably transfected with huIL-12R␤1 and huIL-12R␤2 alone and in combination. Stable Ba͞F3 clones expressing huIL-12R␤1, Ba͞F3.huIL-12R␤1 cells, were isolated on the basis of G-418 resistance. These cells express about 30,000 huIL-12R␤1 molecules on the cell surface (data not shown), as determined using 125 I-labeled Fab fragments of the anti-huIL-12R␤1 monoclonal antibody 2-4E6 (23). As previously reported for the CTLL mouse IL-2-dependent T cell line (17) , 125 I-huIL-12 binds very inefficiently to the Ba͞F3.huIL-12R␤1 cells, with a K d Ͼ 50 nM (data not shown). In contrast, Ba͞F3 cells expressing huIL-12R␤2 and selected in puromycin-containing medium exhibited 125 I-huIL-12 binding with a K d of about 5 nM (Fig. 5 We next examined the ability of huIL-12 to stimulate proliferation of the transfected Ba͞F3 cells. In keeping with the ability to select these cells by long-term growth in huIL-12-containing medium, LJM-1 (cotransfected Ba͞F3) cells proliferated in response to huIL-12 in a dose-dependent fashion (Fig. 5 Bottom) . Ba͞F3.huIL-12R␤2 cells that grew slowly in huIL-12-containing medium were also identified, and subsequent cloning of these huIL-12R␤2 transfectants in the presence of huIL-12 yielded clones that exhibited high levels of huIL-12-stimulated proliferation (Fig. 5 Bottom) . In contrast, we were unable to isolate any Ba͞F3.huIL-12R␤1 cells by long-term growth in huIL-12-containing medium, and Ba͞ F3.huIL-12R␤1 cells selected on the basis of G-418 resistance did not proliferate in response to huIL-12 (Fig. 5 Bottom) . In parallel with the observed lack of high affinity 125 I-huIL-12 binding to the Ba͞F3.huIL-12R␤2 cells, these cells exhibited an ED 50 for IL-12-induced proliferation (50 pM) that was 50-fold greater than that observed with the LJM-1 cells (1 pM).
DISCUSSION
The identification of an IL-12 binding protein that is a ␤-type cytokine receptor subunit and that mediates low-affinity 125 IhuIL-12 binding when expressed in COS-7 cells has been described (17) . This IL-12 receptor protein was originally designated IL-12R␤ and has now been renamed IL-12R␤1. By analogy to other cytokine receptor systems, the inability to confer high-affinity 125 I-huIL-12 binding through expression of IL-12R␤1 suggested that additional receptor protein(s) re- (21) . A cDNA encoding a novel IL-12 receptor protein, designated IL-12R␤2, was thus isolated. This IL-12R␤2 protein, similar to the previously isolated IL-12R␤1 subunit, is a member of the gp130-type subgroup of the cytokine receptor superfamily. Alignment scores for a sequence comparison between the ␤1 and ␤2 subunits of the IL-12R are significant. However, each of the two IL-12R subunits itself is more closely related to gp130 than to each other. In contrast to IL-12R␤1, which does not contain any cytoplasmic tyrosine residues, the cytoplasmic region of IL-12R␤2 contains three tyrosine residues, suggesting an important role for the ␤2 subunit in IL-12 signal transduction. Comparison of the human and mouse IL-12R␤2 proteins reveals a high level of conservation, with a 68% aa sequence identity. This is in contrast to the situation for the IL-12R␤1 subunit, which exhibits only a 54% sequence identity between the human and mouse proteins.
Expression of human IL-12R␤2 in COS-7 cells yielded one class of 125 I-huIL-12 binding sites with a K d of about 5 nM. Although the binding affinity for 125 I-huIL-12 of IL-12R␤1 and IL-12R␤2 expressed in COS-7 cells are similar, we have consistently observed the number of 125 I-huIL-12 binding sites seen with IL-12R␤2-transfected COS-7 cells to be about 10-fold lower than that seen with IL-12R␤1-transfected cells. The reasons for this difference in expression efficiency are not known. In keeping with the fact that IL-12R␤2 was identified using a screen that employed coexpression with IL-12R␤1 and that was optimized for detecting high-affinity 125 I-huIL-12 binding, coexpression of the ␤1 and ␤2 proteins in COS-7 cells yielded high-affinity 125 I-huIL-12 binding. Two classes of binding sites for 125 I-huIL-12, with K d s of about 50 pM and 10 nM, were measured in cotransfected COS-7 cells. These binding affinities are similar to the high-and low-affinity binding sites, with K d s of about 5-20 pM and 2-6 nM, detected on PHAactivated lymphoblasts and the IL-12 responsive Kit225͞K6 T cell line (17, 23) . The observed affinity difference between high-affinity binding in the cotransfected COS-7 cells vs. PHA-activated lymphoblasts is small but very reproducible. Besides this quantitative difference there are also qualitative differences. Certain classes of inhibitors, such as the anti-huIL-12R␤1 mAb 2B10, are able to inhibit IL-12 bioactivity in huIL-12R␤1͞␤2 cotransfected Ba͞F3 cells but not in PHAactivated lymphoblasts (data not shown). However, it is clear that coexpression of both the ␤1 and ␤2 IL-12R chains in COS-7 cells is both necessary and sufficient for high-affinity 125 I-huIL-12 binding. It is unclear whether the observed differences between cotransfected COS-7 or Ba͞F3 cells and PHA-activated lymphoblasts reflect the involvement of additional IL-12R subunits in PHA-activated lymphoblasts or simply differences in posttranslational processing of the two known IL-12R subunits.
The low number of high-affinity binding sites measured on cotransfected cells may be due to the large excess of huIL-12R␤1 expressed in transfected cells. Combined with the propensity for huIL-12R␤2 to form homomultimers (as seen in The apparent molecular weight of the IL-12R␤2 protein monomer when expressed in COS-7 cells was 130 kDa, suggesting that about 36 kDa of carbohydrate are present on the predicted 94-kDa protein backbone. Similar to huIL-12R␤1, huIL-12R␤2 appears to exist at the cell surface as a disulfidebonded dimer͞oligomer. Formation of this huIL-12R␤2 oligomer is not dependent on IL-12 binding, since it was observed in cells that were never exposed to IL-12. Coimmunoprecipitation experiments designed to examine the formation of ␤1͞␤2-containing heterodimers, conducted both in the absence or presence of huIL-12 and chemical crosslinking agents,
have not yet been successful. This could be due to disruption of the ␤1͞␤2 heterodimers by the solubilization procedures, or simply due to insufficient sensitivity of the methods employed since only about 2000 high-affinity 125 I-huIL-12 binding sites per cell are reconstituted on cotransfected COS-7 cells, in the presence of a large excess of ␤1 and ␤2 homomultimers that will interfere with the immunoprecipitation of the heterodimeric complexes.
To address the question of signaling through the IL-12R complex, we used the IL-3-dependent murine pro B cell line These observations suggest that endogenous mouse IL-12R␤1 is not playing a role in the observed IL-12 signaling in huIL-12R␤2 Ba͞F3 transfectants. It is intriguing that the IL-12R␤2 protein, in contrast to the IL-12R␤1 protein, contains cytoplasmic tyrosine residues. By analogy to many other cytokine receptors, these IL-12R␤2 cytoplasmic tyrosine residues are likely to play an important role in IL-12 signal transduction. Within the heterodimeric IL-12R complex, IL-12R␤2 could therefore be considered the signal specificity determining ''driver'' subunit based on the concept outlined by Lai et al. (36) . By bringing Janus kin ase kinases to the receptor complex, the ␤1 subunit would then serve as the more generic ''trigger'' chain. Experiments are underway to determine if this is indeed the case, or if the ␤1 subunit primarily acts as an affinity converter.
In conclusion, we have identified IL-12R␤2, an additional protein subunit of the functional, high-affinity IL-12R complex. IL-12R␤2 appears to have an important function in the IL-12 signal transduction process, and in concert with the previously identified IL-12R␤1 subunit, can confer highaffinity binding and IL-12 responsiveness to cells expressing these proteins. We have produced a cotransfected Ba͞F3 cell line, LJM-1 cells, that binds 125 I-huIL-12 with high affinity, and that proliferates in response to IL-12 with an ED 50 of 1 pM. This IL-12-responsive cell line should be useful for further investigation into IL-12 signal transduction mechanisms.
